FIGURE 3 FIGURE 4 FIGURE 5 BPC 157 retrobulbar application was given as therapy after L-NAME at 20 min or at 48 h, as early therapy (i.e., after L-NAME at 20 min), or as delayed therapy (after L-NAME at 48 h)
Maja Stefanovic-Racic, added that tirzepatides ability to improve erectile function is particularly compelling, as testosterone often falls short in this area for obese men
The investment in a complete cycle generally proves worthwhile for appropriate injuries
Safety Questions to Ask Before Considering Recovery Peptides Before discussing BPC-157, TB-500, or any recovery peptide, patients should ask practical safety questions
| Target Concentration | BAC Water to Add | Dose per 10 units on syringe | |---------------------|-----------------|------------------------------| | 8mg/ml | 3.0ml | 0.8mg | | 12mg/ml | 2.0ml | 1.2mg | | 6mg/ml | 4.0ml | 0.6mg | **Best for:** Patients on 4-8mg weekly doses (therapeutic range)
Tb-500 has more published human clinical data than Bpc-157, including a 40 person safety study showing tolerability up to extremely high doses and a 73 person wound healing study showing 45 percent faster recovery